These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 17233835)

  • 21. MicroRNA-101 inhibits cell proliferation and induces apoptosis by targeting EYA1 in breast cancer.
    Guan H; Dai Z; Ma Y; Wang Z; Liu X; Wang X
    Int J Mol Med; 2016 Jun; 37(6):1643-51. PubMed ID: 27082308
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development.
    Rivas MA; Venturutti L; Huang YW; Schillaci R; Huang TH; Elizalde PV
    Breast Cancer Res; 2012 May; 14(3):R77. PubMed ID: 22583478
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kinesin family member 11 is a potential therapeutic target and is suppressed by microRNA-30a in breast cancer.
    Wang B; Yu J; Sun Z; Luh F; Lin D; Shen Y; Wang T; Zhang Q; Liu X
    Mol Carcinog; 2020 Aug; 59(8):908-922. PubMed ID: 32346924
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The microtubule-associated protein PRC1 promotes early recurrence of hepatocellular carcinoma in association with the Wnt/β-catenin signalling pathway.
    Chen J; Rajasekaran M; Xia H; Zhang X; Kong SN; Sekar K; Seshachalam VP; Deivasigamani A; Goh BK; Ooi LL; Hong W; Hui KM
    Gut; 2016 Sep; 65(9):1522-34. PubMed ID: 26941395
    [TBL] [Abstract][Full Text] [Related]  

  • 25. FOXP3 is a novel transcriptional repressor for the breast cancer oncogene SKP2.
    Zuo T; Liu R; Zhang H; Chang X; Liu Y; Wang L; Zheng P; Liu Y
    J Clin Invest; 2007 Dec; 117(12):3765-73. PubMed ID: 18008005
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Distinct Diagnostic and Prognostic Values of Kinesin Family Member Genes Expression in Patients with Breast Cancer.
    Song X; Zhang T; Wang X; Liao X; Han C; Yang C; Su K; Cao W; Gong Y; Chen Z; Han Q; Li J
    Med Sci Monit; 2018 Dec; 24():9442-9464. PubMed ID: 30593585
    [TBL] [Abstract][Full Text] [Related]  

  • 27. KIF2C promotes clear cell renal cell carcinoma progression via activating JAK2/STAT3 signaling pathway.
    Deng H; Gong X; Ji G; Li C; Cheng S
    Mol Cell Probes; 2023 Dec; 72():101938. PubMed ID: 37863123
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Downregulation of Cohesin Loading Factor Nipped-B-Like Protein (NIPBL) Induces Cell Cycle Arrest, Apoptosis, and Autophagy of Breast Cancer Cell Lines.
    Zhou H; Zheng L; Lu K; Gao Y; Guo L; Xu W; Wang X
    Med Sci Monit; 2017 Oct; 23():4817-4825. PubMed ID: 28987049
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of 17beta-hydroxysteroid dehydrogenase type 7 modulates breast cancer protein profile and enhances apoptosis by down-regulating GRP78.
    Wang XQ; Aka JA; Li T; Xu D; Doillon CJ; Lin SX
    J Steroid Biochem Mol Biol; 2017 Sep; 172():188-197. PubMed ID: 28645527
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CDK16 promotes the progression and metastasis of triple-negative breast cancer by phosphorylating PRC1.
    Li X; Li J; Xu L; Wei W; Cheng A; Zhang L; Zhang M; Wu G; Cai C
    J Exp Clin Cancer Res; 2022 Apr; 41(1):149. PubMed ID: 35449080
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Y-box binding protein 1 is up-regulated in proliferative breast cancer and its inhibition deregulates the cell cycle.
    Yu YN; Yip GW; Tan PH; Thike AA; Matsumoto K; Tsujimoto M; Bay BH
    Int J Oncol; 2010 Aug; 37(2):483-92. PubMed ID: 20596676
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gene expression profiling revealed survivin as a target of 3,3'-diindolylmethane-induced cell growth inhibition and apoptosis in breast cancer cells.
    Rahman KW; Li Y; Wang Z; Sarkar SH; Sarkar FH
    Cancer Res; 2006 May; 66(9):4952-60. PubMed ID: 16651453
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acylglycerol kinase promotes cell proliferation and tumorigenicity in breast cancer via suppression of the FOXO1 transcription factor.
    Wang X; Lin C; Zhao X; Liu A; Zhu J; Li X; Song L
    Mol Cancer; 2014 May; 13():106. PubMed ID: 24886245
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Progesterone receptor-cyclin D1 complexes induce cell cycle-dependent transcriptional programs in breast cancer cells.
    Dressing GE; Knutson TP; Schiewer MJ; Daniel AR; Hagan CR; Diep CH; Knudsen KE; Lange CA
    Mol Endocrinol; 2014 Apr; 28(4):442-57. PubMed ID: 24606123
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Checkpoint suppressor 1 suppresses transcriptional activity of ERα and breast cancer cell proliferation via deacetylase SIRT1.
    Xu Z; Yang Y; Li B; Li Y; Xia K; Yang Y; Li X; Wang M; Li S; Wu H
    Cell Death Dis; 2018 May; 9(5):559. PubMed ID: 29752474
    [TBL] [Abstract][Full Text] [Related]  

  • 36. T-box 2 represses NDRG1 through an EGR1-dependent mechanism to drive the proliferation of breast cancer cells.
    Redmond KL; Crawford NT; Farmer H; D'Costa ZC; O'Brien GJ; Buckley NE; Kennedy RD; Johnston PG; Harkin DP; Mullan PB
    Oncogene; 2010 Jun; 29(22):3252-62. PubMed ID: 20348948
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ELK1-induced up-regulation of KIF26B promotes cell cycle progression in breast cancer.
    Wang S; Zhang H; Liu H; Guo X; Ma R; Zhu W; Gao P
    Med Oncol; 2021 Nov; 39(1):15. PubMed ID: 34817735
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Crk adaptor proteins act as key signaling integrators for breast tumorigenesis.
    Fathers KE; Bell ES; Rajadurai CV; Cory S; Zhao H; Mourskaia A; Zuo D; Madore J; Monast A; Mes-Masson AM; Grosset AA; Gaboury L; Hallet M; Siegel P; Park M
    Breast Cancer Res; 2012 May; 14(3):R74. PubMed ID: 22569336
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transcriptional targeting of gene expression in breast cancer by the promoters of protein regulator of cytokinesis 1 and ribonuclease reductase 2.
    Yun HJ; Cho YH; Moon Y; Park YW; Yoon HK; Kim YJ; Cho SH; Lee YI; Kang BS; Kim WJ; Park K; Seo W
    Exp Mol Med; 2008 Jun; 40(3):345-53. PubMed ID: 18587273
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Involvement of C12orf32 overexpression in breast carcinogenesis.
    Kim JW; Fukukawa C; Ueda K; Nishidate T; Katagiri T; Nakamura Y
    Int J Oncol; 2010 Oct; 37(4):861-7. PubMed ID: 20811708
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.